ES2193008T1 - Gabapentin estable que contiene mas de 20 ppm de un ion de cloro. - Google Patents

Gabapentin estable que contiene mas de 20 ppm de un ion de cloro.

Info

Publication number
ES2193008T1
ES2193008T1 ES01946364T ES01946364T ES2193008T1 ES 2193008 T1 ES2193008 T1 ES 2193008T1 ES 01946364 T ES01946364 T ES 01946364T ES 01946364 T ES01946364 T ES 01946364T ES 2193008 T1 ES2193008 T1 ES 2193008T1
Authority
ES
Spain
Prior art keywords
ppm
chlorine ion
stable gabapentin
stable
gabapentin containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES01946364T
Other languages
English (en)
Other versions
ES2193008T3 (es
Inventor
Claude Singer
Gideon Pilarski
Michael Pesachovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22788993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2193008(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of ES2193008T1 publication Critical patent/ES2193008T1/es
Application granted granted Critical
Publication of ES2193008T3 publication Critical patent/ES2193008T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Composición farmacéutica que comprende gabapentin y que inicialmente contiene menos del 0,5% en peso de un lactamo correspondiente y que presenta más de 20 ppm de un anión de un ácido mineral, que, después de un año de almacenamiento a una temperatura de 25º C y a una humedad del 60%, la conversión de gabapentin en su lactamo correspondiente no excede del 0,2% en peso de gabapentin.
ES01946364T 2000-06-16 2001-06-15 Gabapentina estable que contiene mas de 20 ppm de iones de cloro. Expired - Lifetime ES2193008T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21196700P 2000-06-16 2000-06-16
US211967P 2000-06-16

Publications (2)

Publication Number Publication Date
ES2193008T1 true ES2193008T1 (es) 2003-11-01
ES2193008T3 ES2193008T3 (es) 2004-07-01

Family

ID=22788993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01946364T Expired - Lifetime ES2193008T3 (es) 2000-06-16 2001-06-15 Gabapentina estable que contiene mas de 20 ppm de iones de cloro.

Country Status (12)

Country Link
US (1) US6531509B2 (es)
EP (1) EP1289364B1 (es)
AT (1) ATE255891T1 (es)
AU (1) AU2001268426A1 (es)
CA (1) CA2410867C (es)
DE (2) DE60101476T2 (es)
DK (1) DK1289364T3 (es)
ES (1) ES2193008T3 (es)
IL (1) IL153398A0 (es)
PT (1) PT1289364E (es)
TR (1) TR200302296T4 (es)
WO (1) WO2001097612A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ200339A3 (cs) * 2000-06-16 2003-06-18 Teva Pharmaceutical Industries Ltd. Stabilní gabapentin vykazující neutrální pH
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
KR20050084445A (ko) * 2002-12-20 2005-08-26 다이노젠 파마세우티컬스, 인코포레이티드 α₂δ 서브유닛 칼슘 채널 모듈레이터를 이용한 무통증방광 질환의 치료방법
EP1721607A1 (en) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
WO2005046566A2 (en) * 2003-08-04 2005-05-26 Sun Pharmaceutical Industries Limited Stable gabapentin containing composition
KR20060103440A (ko) * 2003-10-31 2006-09-29 알자 코포레이션 3-아미노-ｎ-부틸-포스핀산의 개선된 흡수를 위한 조성물및 제형
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CN101462975B (zh) * 2008-08-19 2012-07-25 宁波九胜创新医药科技有限公司 一种高纯度加巴喷丁的制备方法
CN116693410B (zh) * 2023-06-08 2024-06-07 浙江竹子制药有限公司 一种粒径可控的加巴喷丁制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2611690A1 (de) 1976-03-19 1977-09-22 Goedecke Ag Cyclische sulfonyloxyimide
US4960931A (en) 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) * 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928183A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
DE3928182A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
DE3928184A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
US5132451A (en) 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
FI107914B (fi) 1989-08-25 2001-10-31 Warner Lambert Co Parannettu menetelmä syklisten aminohappoyhdisteiden valmistamiseksi ja menetelmässä käytettävä välituote
US5319135A (en) 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
AU769038B2 (en) * 1998-05-15 2004-01-15 Warner-Lambert Company Llc Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
AU768277B2 (en) * 1998-05-15 2003-12-04 Warner-Lambert Company Llc Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
FR2781793B1 (fr) 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same

Also Published As

Publication number Publication date
DE60101476T2 (de) 2004-05-27
TR200302296T4 (tr) 2004-02-23
US20020061931A1 (en) 2002-05-23
PT1289364E (pt) 2004-04-30
CA2410867C (en) 2003-12-09
ATE255891T1 (de) 2003-12-15
ES2193008T3 (es) 2004-07-01
CA2410867A1 (en) 2001-12-27
DK1289364T3 (da) 2004-04-13
EP1289364A1 (en) 2003-03-12
EP1289364B1 (en) 2003-12-10
DE1289364T1 (de) 2003-09-18
EP1289364A4 (en) 2003-08-06
WO2001097612A1 (en) 2001-12-27
IL153398A0 (en) 2003-07-06
AU2001268426A1 (en) 2002-01-02
US6531509B2 (en) 2003-03-11
DE60101476D1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
ES2193008T1 (es) Gabapentin estable que contiene mas de 20 ppm de un ion de cloro.
BR0211390A (pt) Tratamento de infecções da unha com no
HK1045705A1 (zh) 含水楊酸硅氧烷凝膠
UY24354A1 (es) Composiciones farmacéuticas que contienen epinastina
MXPA04004109A (es) Composiciones cosmeticas anhidras que contienen compuestos de amonio cuaternario.
ATE198143T1 (de) Zahnpasten
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
DE69905170D1 (en) Thiazolopyrimidinderivate
MXPA02006826A (es) Un inhibidor de division celular y un metodo de produccion del mismo.
MXPA04006542A (es) Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluooruro.
BR0207315A (pt) Análogos de ácido ascórbico para metalorradiofármacos
MXPA04001231A (es) Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico.
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
EA200400259A1 (ru) Дезинфицирующий раствор на основе гипохлорита натрия и способ его получения
ES2187428T3 (es) Composiciones que contienen agua mineral.
FR2804319B1 (fr) Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
BR0210348A (pt) Material polimérico, contendo um ácido latente
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
BR0313570A (pt) Agente, e, uso do mesmo
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater